Circulomics is a Maryland biotechnology company that spun out of a $14M Cancer Nanomedicine Center at Johns Hopkins to commercialize multiplexed assays for molecular and biomarker analysis. In recent years, microRNA biomarkers have been propelled to the forefront of medical research based on their unparalleled ability to accurately identify cancer and other disease states. Circulomics has received $1.3M in grant funding to develop innovative platforms for microRNA profiling, single molecule analysis, and nucleic acid extraction that will drive the research and rapid clinical translation of these promising biomarkers.
Circulomics’ innovative Ligo-miR assay platform will be leveraged into a line of microRNA research tools and cancer diagnostic assays. The 1st product will be an assay kit for cancer research called Ligo-miR EZ. Ligo-miR EZ is a high volume sales product that can reach the market quickly and rapidly gain market share by having exceptionally low barriers to adoption.